Skip to main content

Client News

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

11th February 2025

MIG Capital and CoreMedic Announce Fresh Funding in Series B Extension

11th February 2025

Lotus Pharmaceutical Becomes Strategic Partner for the Commercialization of Formycon’s Eylea® Biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region

5th February 2025

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

4th February 2025

Affluent Medical Announces 10th Successful Human Implantation of its Artus Urinary Sphincter, Marking Completion of the Pilot Phase

30th January 2025

Rentschler Biopharma Announces Atrategic Realignment of its Global Business Operations

30th January 2025

Abivax Publishes 2025 Financial Calendar

28th January 2025

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

27th January 2025

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress

23rd January 2025

InflaRx Announces Participation in Guggenheim SMID Cap Biotech Conference

23rd January 2025